Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Setsuko K Chambers

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|September 25, 2013
Secretory cell expansion with aging: risk for pelvic serous carcinogenesisJie Li, Yan Ning, Nisreen Abushahin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 22, 2014
Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidenceChristine Gruessner, Angelika Gruessner, Katherine Glaser, et al.
Lasers in Surgery and Medicine|April 21, 2020
Fluorescence and Multiphoton Imaging for Tissue Characterization of a Model of Postmenopausal Ovarian CancerTravis W Sawyer, Jennifer W Koevary, Caitlin C Howard, et al.
Comparative Medicine|December 29, 2018
Comparison of Reproductive Function in Female <i>TgMISIIR-TAg</i> Transgenic and Wildtype C57BL/6 MicePatricia B Hoyer, Photini F Rice, Caitlin C Howard, et al.
Journal of Biomedical Optics|March 29, 2014
Simultaneous multiplane imaging of human ovarian cancer by volume holographic imagingGabriel V Orsinger, Jennifer M Watson, Michael Gordon, et al.
BMC Medicine|September 8, 2022
Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolutionXuexin Yu, Wanrun Lin, Alexandra Spirtos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancerSetsuko K Chambers, H-H Sherry Chow, Mike F Janicek, et al.
Gynecologic Oncology|October 13, 2015
Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group studyLisa M Hess, Helen Q Huang, Alexandra L Hanlon, et al.
Journal of Biomedical Optics|May 26, 2016
Multispectral fluorescence imaging of human ovarian and fallopian tube tissue for early-stage cancer detectionTyler H Tate, Brenda Baggett, Photini F S Rice, et al.
Science Advances|February 1, 2023
NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8Annadurai Anandhan, Matthew Dodson, Aryatara Shakya, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|September 25, 2013
Secretory cell expansion with aging: risk for pelvic serous carcinogenesisJie Li, Yan Ning, Nisreen Abushahin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 22, 2014
Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidenceChristine Gruessner, Angelika Gruessner, Katherine Glaser, et al.
Lasers in Surgery and Medicine|April 21, 2020
Fluorescence and Multiphoton Imaging for Tissue Characterization of a Model of Postmenopausal Ovarian CancerTravis W Sawyer, Jennifer W Koevary, Caitlin C Howard, et al.
Comparative Medicine|December 29, 2018
Comparison of Reproductive Function in Female <i>TgMISIIR-TAg</i> Transgenic and Wildtype C57BL/6 MicePatricia B Hoyer, Photini F Rice, Caitlin C Howard, et al.
Journal of Biomedical Optics|March 29, 2014
Simultaneous multiplane imaging of human ovarian cancer by volume holographic imagingGabriel V Orsinger, Jennifer M Watson, Michael Gordon, et al.
BMC Medicine|September 8, 2022
Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolutionXuexin Yu, Wanrun Lin, Alexandra Spirtos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancerSetsuko K Chambers, H-H Sherry Chow, Mike F Janicek, et al.
Gynecologic Oncology|October 13, 2015
Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group studyLisa M Hess, Helen Q Huang, Alexandra L Hanlon, et al.
Journal of Biomedical Optics|May 26, 2016
Multispectral fluorescence imaging of human ovarian and fallopian tube tissue for early-stage cancer detectionTyler H Tate, Brenda Baggett, Photini F S Rice, et al.
Science Advances|February 1, 2023
NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8Annadurai Anandhan, Matthew Dodson, Aryatara Shakya, et al.
Pageof 7